pre-splenectomy

Nimenrix®

Meningococcal A,C,Y,W135 conjugate vaccine

Nimenrix® is a meningococcal A,C,Y,W-135 conjugate vaccine used to protect against four groups of Neisseria meningitidis, group A, group C, group Y and group W-135.

Nimenrix® is used as an alternative vaccine to the meningococcal C conjugate vaccine (Neisvac-C™), meningococcal A,C,Y,W-135 conjugate vaccine (Menactra®) and the meningococcal A,C,Y,W-135 polysaccharide vaccine (Mencevax® ACYW).

The conjugate and polysaccharide vaccines work differently to generate protection against the bacteria. Protection from the conjugate vaccines lasts longer than that from the polysaccharide vaccines. The conjugate vaccines also generate long term memory cells allowing rapid boosting of immunity years later.

Menomune® ACYW-135

Meningococcal A,C,Y,W135 polysaccharide vaccine

There are no supplies of Menomune® currently in New Zealand. Menactra® and Nimenrix® are alternative vaccine brands. Menomune® is used for vaccination of children two years of age and over and adults to protect against four groups of Neisseria meningitidis, group A, group C, group Y and group W-135.

Act-HIB®

Haemophillus influenzae type b (Hib)

Act-HIB® is used for a booster vaccination at 15 months of age to protect against disease caused by Haemophilus influenzae type b. The vaccine is also used for vaccination of children aged 5 years of age and over and adults with some chronic medical conditions.

Menactra®

Meningococcal A,C,Y,W135 conjugate vaccine

Menactra® is a meningococcal A,C,Y,W-135 conjugate vaccine used to protect against four groups of Neisseria meningitidis, group A, group C, group Y and group W-135.

Menactra® is used as an alternative vaccine to the meningococcal C conjugate vaccine (Neisvac-C™), meningococcal A,C,Y,W-135 conjugate vaccine (Nimenrix®) and the meningococcal A,C,Y,W-135 polysaccharide vaccine (Mencevax® ACYW).

The conjugate and polysaccharide vaccines work differently to generate protection against the bacteria. Protection from the conjugate vaccines lasts longer than that from the polysaccharide vaccines. The conjugate vaccines also generate long term memory cells allowing rapid boosting of immunity years later.

Mencevax® ACWY

Meningococcal A,C,Y,W135 polysaccharide vaccine

Supply of Mencevax® ACWY has been discontinued in New Zealand. Menactra® and Nimenrix® are alternative vaccine brands.

Meningitec®

Meningococcal C conjugate vaccine

Supply of Meningitec® has been discontinued in New Zealand. NeisVac-C®, Menactra® and Nimenrix® are alternative vaccine brands.

NeisVac-C®

Meningococcal C conjugate vaccine

NeisVac-C® is a meningococcal C conjugate vaccine used to protect against Neisseria meningitidis group C only.

The conjugate and polysaccharide vaccines work differently to generate protection against the bacteria. Protection from the conjugate vaccines lasts longer than that from the polysaccharide vaccines. The conjugate vaccines also generate long term memory cells allowing rapid boosting of immunity years later.

 

Subscribe to RSS - pre-splenectomy